Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome

NCT00475020 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: Busulfan
DRUG: Fludarabine
DRUG: Thymoglobulin (ATG)

Sponsor

M.D. Anderson Cancer Center